drugset / Trial / NCT00257790
The Tobramycin Study
Phase 4
Completed
210 enrolled
Oslo University Hospital
Sentralsjukehuset i Hedemark · collabSentralsjukehuset i Rogaland · collabSorlandet Hospital HF · collabSykehuset Asker og Baerum · collabSykehuset Buskerud · collabSykehuset Innlandet HF · collabThe Hospital of Vestfold · collabThe National Institute of Health, Oslo · collabUllevaal University Hospital · collab
RandomizedSingle-groupOpen-labelTreatment
Summary
Evaluate if tobramycin given once a day is at least as efficacious as the traditional tobramycin given three times a day, given with penicillin G, til patients with febrile neutropenia.
Timeline
- Start
- 2001-09
- Primary completion
- —
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tobramycin | Small molecule | 6 mg/kg | — |